NASDAQ OMX

Jeffrey Sachs to Open 1st World Coffee Producers Forum in Colombia

14.6.2017 23:39 | NASDAQ OMX

Dela

Coffee farmers and industry stakeholders from over 40 countries will address sustainability challenges of the coffee value chain under a co-responsibility approach.

The ICO Executive Director, the President of Colombia and the CEO of the Colombian Coffee Growers Federation (FNC) will also take part in the opening ceremony, along with representatives of African, Asian and Latin American coffee producers.

BOGOTÁ, Colombia, June 14, 2017 (GLOBE NEWSWIRE) -- (FNC Press Office) - The First World Coffee Producers Forum, to be held in Medellín, Colombia, from July 10 to 12, will be opened by the expert and leader in sustainable development Professor Jeffrey D. Sachs as keynote speaker.

The program of the First World Coffee Producers Forum includes speakers, analysts and guests of international stature, and will address issues that affect the entire coffee industry, making this event a must.

A world-renowned professor of economics, senior UN advisor, bestselling author, and syndicated columnist, Professor Sachs is currently the director of both the Center for Sustainable Development (at the Columbia University) and the UN Sustainable Development Solutions Network.

The Executive Director of the International Coffee Organization (ICO), José Sette; the President of Colombia, Juan Manuel Santos, and the CEO of the Colombian Coffee Growers Federation (FNC), Roberto Velez, will also participate in the opening ceremony, along with representatives of African, Asian and Latin American coffee producers.

The First World Coffee Producers Forum aims at addressing the challenges that could prevent the value chain from being sustainable in the future, such as a more equitable distribution of income, with an approach of co-responsibility of all stakeholders.

Bringing Together Coffee Producers and Key Actors of the Global Industry

The forum's academic agenda will address issues that are common challenges to all coffee-producing countries and pose a threat to the industry as a whole. Economic sustainability of coffee growers, rural development, socio-economic indicators, climate change adaptation, productivity, price volatility, generational change, and labor are some of them.

Thematic working groups and panels will analyze challenges of coffee production and trading and make recommendations on how to deal with them.

Other figures of international stature attending the forum as moderators or speakers are Ric Rhinehardt, Executive Director and CEO of the Specialty Coffee Association (SCA); Fred Kawuma, Secretary General of the Inter-African Coffee Organization (IACO); Silas Brasileiro, Executive President of Brazil's National Coffee Council (NCC) and Annette Pensel, Executive Director of the Global Coffee Platform.

Ronald Peters, Executive Director of Costa Rica's Coffee Institute (Icafé); René León, Executive Secretary of Promecafé; Ishak Lukenge, President of the Uganda Chapter and Chairman of the Board of Directors of the African Fine Coffees Association (AFCA), and Vanusia Nogueira, Executive Director of the Brazil Specialty Coffee Association (BSCA) will also participate in the forum as moderators or panel members.

Among industry representatives attending the forum, including global companies like Starbucks, several will also take part as speakers or panelists, such as Marcelo Burity, Head of Green Coffee Development at Nestlé, and Andrea Illy, Chairman of Illycaffè.

During the whole conference, attendees will be able to taste coffees from all the producing countries that will participate in the forum.

Given the great interest that this event has drawn (including a two-day field trip to the central Colombian coffee region) and that places are limited, those interested in attending must register at:

http://www.worldcoffeeproducersforum.com/es
http://www.worldcoffeeproducersforum.com/

About the FNC
Created in 1927, the Colombian Coffee Growers Federation (FNC, Federación Nacional de Cafeteros) represents over 560,000 Colombian coffee growers. With a vision of environmental, economic and social sustainability, its mission is to work for the well-being of Colombian coffee growers and their families. It provides public goods and services and develops specific programs and strategies that help them climb the value chain and improve their quality of life.

Contact Information:
Federación Nacional de Cafeteros de Colombia
Jenny Vanessa Cuervo
(57+1) 3136600 Ext. 1697



This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Federacion Nacional de Cafeteros de Colombia-Fondo Nacional del Café via Globenewswire

Om

NASDAQ OMX
NASDAQ OMX



Följ NASDAQ OMX

Skriv in din e-postadress så får du ett mejl när vi har något nytt att berätta.

Senaste nyheterna från NASDAQ OMX

LifeSci Advisors' Board Placement Initiative Announces Ninth Board Placement23.6.2017 17:52Pressmeddelande

NEW YORK, June 23, 2017 (GLOBE NEWSWIRE) -- LifeSci Advisors, a leading life sciences-focused investor relations consultancy, announced today the ninth placement of a female executive to a life sciences company board as part of their Board Placement Initiative (BPI), a program launched a year ago with the goal to connect female executives in the life sciences industry with companies looking for board candidates. LifeSci is pleased to share news of the appointment of Jean M. Franchi to the Board of Directors of Biophytis, a biotech company listed on Euronext Paris (ALBPS) focused on drugs that target diseases of aging, with drug candidates in clinical development for dry AMD and Sarcopenia. "I'm honored to join the Biophytis board, and look forward to helping the company achieve a more global presence as it advances its portfolio of innovative therapies addressing unmet needs associated with aging," said Ms. Franchi. "I want to extend my kind thanks to LifeSci

Fentress Architects Announces its Annual Student Global Challenge23.6.2017 09:00Pressmeddelande

6th edition invites students to re-envision the terminal building in the year 2075 Denver, Colorado, June 23, 2017 (GLOBE NEWSWIRE) -- Fentress Architects, based in Denver, Colorado, announces the 2017 Fentress Global Challenge, an international design competition for young and student architects. As in years past, the theme, consistent with the firm's expertise in airport design and aviation, is envisioning an airport of the future.  Participants are encouraged to re-envision the terminal building in the year 2075 using one of 10 existing international airports, taking into consideration local context, technological trends, and project feasibility and passenger experience. This is the sixth year that Fentress Architects has sponsored and administered the award, which brings a First Prize of $15,000 and a summer internship at Fentress' Denver office; four additional winners will receive smaller cash awards.

Oxford Immunotec Announces National Reimbursement for the T-SPOT®.TB Test in France22.6.2017 22:50Pressmeddelande

OXFORD, United Kingdom and MARLBOROUGH, Mass., June 22, 2017 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq:OXFD), a global, high-growth diagnostics company focused on developing and commercializing proprietary tests for the management of underserved immune-regulated conditions, today announced a decision from the French Ministry of Health and Social Affairs to reimburse interferon gamma release assays, or IGRAs, for latent TB screening in at risk patient populations. Upon implementation of the new reimbursement codes, which is expected in the next 21 days, the French Ministry of Health and Social Affairs will provide reimbursement for the T-SPOT. TB  test at a rate of approximately 60 Euros per test. About Oxford Immunotec Oxford Immunotec Global PLC is a global, high-growth diagnostics company focused on developing and commercializing proprietary tests for the management of underserved immune-r

Standard Lithium Raises $7.4 Million in Oversubscribed Financing22.6.2017 21:49Pressmeddelande

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, June 22, 2017 (GLOBE NEWSWIRE) -- Standard Lithium Ltd. ("Standard Lithium" or the "Company") (TSXV:SLL) (FRA:S5L) is pleased to announce that it has completed the private placement of 9,894,785 common shares at a price of $0.75 per share for gross proceeds of $7,421,089.  Interest in the placement far exceeded the expectations of the Company, and the additional amount raised provides the Company with the capital needed to advance its current projects and pursue strategic acquisitions in the lithium sector. "We are extremely pleased with the interest received in this placement, and completion represents a significant milestone for the Company," commented Anthony Alvaro, a director of the Company.  "The strong demand speaks to the growing confidence in our team, projects and futur

IAGC: Plankton Study Speculative and Needs Better Data22.6.2017 16:08Pressmeddelande

Houston, TX, US, June 22, 2017 (GLOBE NEWSWIRE) -- The International Association of Geophysical Contractors (IAGC) released the following statement regarding the publishing of research on the interaction of seismic surveys and zooplankton in Nature: Ecology and Evolution. The IAGC President, Nikki Martin issued the following statement: "While we found the study interesting, we are also troubled by the small sample sizes, the large day-to-day variability in both the baseline and experimental data, and the large number of speculative conclusions that appear inconsistent with the data collected over a two-day period.  Both statistically and methodologically, this project falls short of what would be needed to provide a convincing case for adverse effects from geophysical survey operations.  "Although the initial report is peer-reviewed, it has not been widely accepted by the expert scientific community.  We look forward to discussing this topic further with

Minerva Announces Completion of Bridging Study to Select Improved Formulation of MIN-101 for Use in Phase 3 Trial for the Treatment of Negative Symptoms in Patients With Schizophrenia22.6.2017 14:30Pressmeddelande

New formulation observed to improve safety margin while offering bioequivalent exposure to prior formulation Company to proceed with initiation of Phase 3 trial on schedule in second half of 2017 CMC scale-up work for NDA preparation initiated WALTHAM, Mass., June 22, 2017 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NASDAQ:NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central nervous system (CNS) disorders, today announced the successful completion of a bridging trial to select an improved, gastric-resistant (GR) formulation of MIN-101. The Company plans to use the selected formulation in its upcoming Phase 3 clinical trial, which remains on schedule for initiation in the second half of 2017, as well as for the potential future submission of a New Drug Application (NDA). 

I vårt nyhetsrum kan du läsa de senaste nyheterna, få tillgång till pressmaterial och hitta kontaktinformation.

Besök vårt nyhetsrum